Skip to content

Evaluation of Eye Health Benefits of Blueberry Chewable Tablets

Evaluation of Eye Health Benefits of Blueberry Chewable Tablets

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04348110
Enrollment
57
Registered
2020-04-15
Start date
2020-04-17
Completion date
2020-12-31
Last updated
2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye

Brief summary

To assess the efficacy of blueberry chewable tablets on Eye Health

Interventions

DIETARY_SUPPLEMENTPlacebo tablets

consume 2 tablets per day for 8 weeks

DIETARY_SUPPLEMENTBlueberry Chewable Tablets

consume 2 tablets per day for 8 weeks

Sponsors

TCI Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult men and women over 20 years old * Use 3C products over 6 hours per day * Symptoms of dry eyes or tired eyes * Tear Break-Up Time is 10 seconds less * No history of ocular surgery (strabismus surgery, refractive surgery etc.)

Exclusion criteria

* Have systemic diseases affecting the front surface of the eyes. * Long-term use of drugs or eye drops that affect the condition of the front surface of the eyes * Long-term contact lens wear

Design outcomes

Primary

MeasureTime frameDescription
Changes of Schirmer's test8 weeksSchirmer's test determines whether the eye produces enough tears to keep it moist. Units: mm (in 5minutes)
Changes of tear meniscus height8 weeksSlit lamp Ocular Surface Analyzer is utilized to measure tear meniscus height. Units: mm
Changes of non-invasive tear break-up time (NITBUT)8 weeksOcular Surface Analyzer is utilized to measure non-invasive tear break-up time. Units: sec
Tear break-up time (TBUT)8 weeksSlit lamp ocular Surface Analyzer is utilized to measure fist tear break-up time with slit lamp. Units: sec
Changes of accommodation8 weeksSpeedy-I is utilized to measure the accommodative micro fluctuation test of the ciliary muscle. Units: HFC
Ocular Surface Disease Index (OSDI)8 weeksThe Ocular Surface Disease Index (OSDI) is a 12-item scale for the assessment of symptoms related to dry eye disease and their effect on vision. Units: point

Secondary

MeasureTime frameDescription
Changes of Amplitude of Flipper facility8 weeksVergence facility (VF) was measured by using a prism flipper to evaluate the ability of the fusional vergence at near with +/-2.00 flipper. Units: cpm
Changes of eye pressure8 weeksEye pressure is measured in millimeters of mercury (mm Hg).
Changes of Fundus photography8 weeksThe fundus is the back of the eye and includes the retina, optic nerve, and retinal blood vessels.
Changes of Intraocular pressure (IOP)8 weeksEye pressure is measured in millimeters of mercury (mm Hg). Units: mmHg
Changes of Near point of convergence (NPC)8 weeksRAF rule were initiated in order to normalize NPC. Record as break/recovery. Units: cm
Changes of Stereo vision8 weeksThe Randot Stereotest is utilized to evaluate the depth perception. Units: sec
Changes of binocular motor fusion8 weeksThe test is utilized to evaluate to assess binocular motor fusion, specifically the extent to which a patient can maintain binocular single vision (BSV) in the presence of increasing vergence demands. Units: prism
Changes of Amplitude of accommodation (AA)8 weeksThe amplitude of accommodation is the maximum potential increase in optical power that an eye can achieve in adjusting its focus. It refers to a certain range of object distances for which the retinal image is as sharply focused as possible. Units: diopter

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026